WMSA
CBAY

Weiss Multi-Strategy Advisers’s Cymabay Therapeutics CBAY Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-65,000
Closed -$333K – 817
2019
Q3 		$333K Hold
65,000
– – 0.01% 515
2019
Q2 		$465K Sell
65,000
-15,000
-19% -$170K 0.02% 427
2019
Q1 		$1.06M Buy
80,000
+18,000
+29% +$191K 0.04% 387
2018
Q4 		$488K Buy
62,000
+6,936
+13% +$66K 0.03% 350
2018
Q3 		$610K Buy
55,064
+241
+0.4% +$2.99K 0.03% 428
2018
Q2 		$736K Buy
54,823
+13,823
+34% +$173K 0.03% 467
2018
Q1 		$533K Buy
41,000
+16,000
+64% +$199K 0.02% 460
2017
Q4 		$230K Buy
+25,000
New +$214K 0.01% 529

Other funds holding CBAY

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return